Show items per page
Elements: 76
Page 2 on 4
 TitleAuthors / EditorsDate
add to browser selection
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance Cantley, Jennifer L; Yoshimura, Toru; Camporez, Joao Paulo G; Zhang, Dongyan; ... Shulman, Gerald I 2013
add to browser selection
Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice Camporez, João Paulo G; Jornayvaz, François; Petersen, Max C; Pesta, Dominik; ... Shulman, Gerald I 2013
add to browser selection
Sport et diabète de type 1 Büsser, Claudio; Meyer, Patrick; Philippe, Jacques; Jornayvaz, François 2013
add to browser selection
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance Asrih, Mohamed; Jornayvaz, François 2013
add to browser selection
Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside Gariani, Karim; Philippe, Jacques; Jornayvaz, François 2013
add to browser selection
Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice Lee, Hui-Young; Gattu, Arijeet K; Camporez, João-Paulo G; Kanda, Shoichi; ... Samuel, Varman T 2014
add to browser selection
Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity Wheeler, Sadie G; Hammond, Christine L; Jornayvaz, François; Samuel, Varman T; ... Ballatori, Nazzareno 2014
add to browser selection
Diets and nonalcoholic fatty liver disease: The good and the bad Asrih, Mohamed; Jornayvaz, François 2014
add to browser selection
Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes Jornayvaz, François 2014
add to browser selection
Traitement combiné d’insuline et d’analogue du GLP-1 : qu’en attendre ? De Kalbermatten, Bénédicte Anne; Jaafar, Jaafar; Jornayvaz, François; Philippe, Jacques 2014
add to browser selection
Maladies hépatiques chroniques et diabète Jaafar, Jaafar; De Kalbermatten, Bénédicte Anne; Philippe, Jacques; Scheen, André; Jornayvaz, François 2014
add to browser selection
Metformine : nouvelles données pour une ancienne molécule Sanduloviciu, Maria; Jornayvaz, François 2015
add to browser selection
Endocrine causes of nonalcoholic fatty liver disease Marino, Laura; Jornayvaz, François 2015
add to browser selection
Classification du diabète : vers une hétérogénéité croissante Corcillo Vionnet, Antonella; Jornayvaz, François 2015
add to browser selection
ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content Camporez, João Paulo G; Kanda, Shoichi; Petersen, Max C; Jornayvaz, François; ... Shulman, Gerald I 2015
add to browser selection
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Asrih, Mohamed; Jornayvaz, François 2015
add to browser selection
Edulcorants artificiels et diabète : faux amis ? Tran, Christel; Jornayvaz, François 2015
add to browser selection
Prise en charge des facteurs de risque des maladies cardiovasculaires : qu’est-ce qui a vraiment changé en 15 ans ? Barthel, Constant; Nanchen, David; Jornayvaz, François; Wuerzner, Grégoire; Senn, Nicolas 2015
add to browser selection
Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue Asrih, Mohamed; Altirriba Gutierrez, Jorge; Rohner-Jeanrenaud, Françoise; Jornayvaz, François 2015
add to browser selection
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21 Camporez, João Paulo G; Asrih, Mohamed; Zhang, Dongyan; Kahn, Mario; ... Jornayvaz, François 2015
| 1 | 2 | 3 | 4 |